Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amplified bioactive signaling and proteolytic enzymes following ischemia reperfusion and aging: remodeling pathways that are not like a fine wine.

× No keyword cloud information.

14 in total

1. Studies in Infarction: IV. Experimental bland Infarction of the Myocardium, Myocardial Regeneration and Cicatrization.

Authors: H T Karsner; J E Dwyer
Journal: J Med Res Date: 1916-03

2. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.

Authors: Bodh I Jugdutt; Anwar Jelani; Ariv Palaniyappan; Halliday Idikio; Richard E Uweira; Vijay Menon; Catherine E Jugdutt
Journal: Circulation Date: 2010-07-12 Impact factor: 29.690

3. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

Authors: Merry L Lindsey; Danielle K Goshorn; Christina E Squires; G Patricia Escobar; Jennifer W Hendrick; Joseph T Mingoia; Sarah E Sweterlitsch; Francis G Spinale
Journal: Cardiovasc Res Date: 2004-12-13 Impact factor: 10.787

4. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.

Authors: Carson S Webb; David D Bonnema; S Hinan Ahmed; Amy H Leonardi; Catherine D McClure; Leslie L Clark; Robert E Stroud; William C Corn; Laura Finklea; Michael R Zile; Francis G Spinale
Journal: Circulation Date: 2006-08-21 Impact factor: 29.690

5. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

Authors: M St John Sutton; M A Pfeffer; L Moye; T Plappert; J L Rouleau; G Lamas; J Rouleau; J O Parker; M O Arnold; B Sussex; E Braunwald
Journal: Circulation Date: 1997-11-18 Impact factor: 29.690

6. Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Authors: Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; D Dirk Bonnema; Michael R Zile
Journal: Am J Physiol Heart Circ Physiol Date: 2009-12-11 Impact factor: 4.733

7. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.

Authors: Marcin Bujak; Hyuk Jung Kweon; Khaled Chatila; Na Li; George Taffet; Nikolaos G Frangogiannis
Journal: J Am Coll Cardiol Date: 2008-04-08 Impact factor: 24.094

Amplified bioactive signaling and proteolytic enzymes following ischemia reperfusion and aging: remodeling pathways that are not like a fine wine.

1. Studies in Infarction: IV. Experimental bland Infarction of the Myocardium, Myocardial Regeneration and Cicatrization.

2. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.

3. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

4. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.

5. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

6. Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

7. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.

Review 8. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

9. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor.

Review 10. Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart.

1. The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats.